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Aerobic exerciseThere is considerable support for the view that aerobic exercisemay confer cognitive beneﬁts tomild cognitively im-
paired elderly persons. However, the biological mechanismsmediating these effects are not entirely clear. As a pre-
liminary step towards informing this gap in knowledge, we enrolled older adults conﬁrmed to have mild cognitive
impairment (MCI) in a 6-month exercise program.Male and female subjects were randomized into a 6-month pro-
gram of either aerobic or stretch (control) exercise. Data collected from the ﬁrst 10 completers, aerobic exercise
(n = 5) or stretch (control) exercise (n = 5), were used to determine intervention-induced changes in the global
gene expression proﬁles of the aerobic and stretch groups. Using microarray, we identiﬁed genes with altered ex-
pression (relative to baseline values) in response to the 6-month exercise intervention. Genes whose expression
were altered by at least two-fold, and met the p-value cutoff of 0.01 were inputted into the Ingenuity Pathway
Knowledge Base Library to generate gene-interaction networks. After a 6-month aerobic exercise-training, genes
promoting inﬂammation became down-regulated, whereas genes having anti-inﬂammatory properties and those
modulating immune function or promoting neuron survival and axon growth, became up-regulated (all fold
change ≥±2.0, p b 0.01). These changes were not observed in the stretch group. Importantly, the differences in
the expression proﬁles correlatedwith signiﬁcant improvement inmaximal oxygenuptake (VO2max) in the aerobic
program as opposed to the stretch group. We conclude that three distinct cellular pathways may collectively
inﬂuence the training effects of aerobic exercise in MCI subjects. We plan to conﬁrm these effects using rt-PCR
and correlate such changes with the cognitive phenotype.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Neuroinﬂammation, a prevalent feature of Alzheimer's disease (AD),
is heralded by insoluble protein deposition, reactive astrocytes, activat-
ed microglia, dystrophic neurites, and intracellular neuroﬁbrillary tan-
gles (NFTs) (Selkoe, 2001; Lue et al., 1996; Hoozemans et al., 2006).
Abundant evidence suggests that inﬂammatory mechanisms within
the central nervous system (CNS) likely promote cognitive deteriora-
tion (Lee et al., 2009). AD progression is marked by uncontrolled glial
cell activation, neuroinﬂammation and consequent neuronal/synapticard University Hospital, 2041
).
. This is an open access article underdysfunction, inciting a vicious cycle of increased glial activation and
neuronal damage (Mrak and Grifﬁn, 2005). Therefore, strategies to re-
duce neuroinﬂammation may attenuate the risk of sporadic AD (Vlad
et al., 2008).
Physical activity can reduce inﬂammation (Braskie et al., 2014), and
has been demonstrated to improve memory in MCI and possibly AD
subjects (Buchman et al., 2012). In support of this view, but through a
yet undiscerned mechanism, moderate exercise reduced amyloid plaque
burden in transgenic mouse models of AD, and improved cognitive func-
tion (Adlard et al., 2005). Independently, aerobic exercise can modulate
immune response, increase the population of regulatory T cells, decrease
the population of inﬂammatory monocytes, and down-regulate inﬂam-
mation (Boas et al., 1996; Gleeson et al., 2011; McTiernan, 2008, 2004;
Ouchi et al., 2011; Spence et al., 2010). However, whether pro-
inﬂammatory proteins facilitating cell death or anti-inﬂammatory genesthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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ulatory mechanism has not been systematically examined in MCI sub-
jects. Importantly, data are lacking on the mechanisms underlying the
beneﬁcial effects of exercise in African American (AA) MCI subjects. As
a preliminary step to this investigative exercise, we examined the
training-induced changes in the overall gene expression proﬁle from
blood cells of MCI volunteers randomized into a 6-month aerobic
exercise-training program versus a stretch-exercise control group. We
hypothesized that aerobic training adaptation would promote favorable
changes in the expression of pro-inﬂammatory or anti-inﬂammatory
genes, and of genesmodulating immune response or promoting neuronal
survival. Since MCI is prodromal for AD, insight into these mechanisms
may inform the development of interventions and treatment regimens
for AD patients.
2. Material and methods
The protocols used in this investigation were approved by the How-
ard University Institutional Review Board (IRB). As required for studies
involving human subjects, all participants completed a signed informed
consent form prior to enrollment in the study.
2.1. Level I screening
Main eligibility criteria used for inclusion consisted of the following:
age N 55 years; ability to exercise vigorously without causing harm to
self; diagnostic designation as MCI according to Petersen criteria
(Petersen, 2004) using education adjusted scores; have a committed
study partner; be in good general health; and willing to exercise for
the entire study duration; and undergo required medical and study-
related assessments. After obtaining informed consent from volunteers,
we collected data on demographics and general medical history. Based
on this initial evaluation, we excluded volunteers with the following his-
tory: head trauma, uncontrolled diabetes mellitus and hypertension;
current chronic renal, liver, respiratory or neurologic disorders; recent
myocardial infarction (within the previous 6 months), and unstable an-
gina. Also excluded were persons using hormone replacement therapy
(HRT) or medications that may affect memory (e.g., anticholinergics,
sedative hypnotics, narcotics, and antiparkinsonian agents). Volunteers
having unstable medical conditions, evidenced by starting new medica-
tions within 6 weeks of enrollment, and those having history of chronic
alcohol and drug abuse, were also excluded from the study. Subjects
were allowed to continue using medications to treat AD (Reminyl,
Aricept, Exelon, Namenda, and Ginkgo Biloba).
Diagnosis of MCI was made using the following criteria:
memory complaints, education adjusted Mini-Mental State Ex-
amination (MMSE) scores, where the adjusted MMSE = raw
MMSE − (0.471 × [education − 12]) + (0.131 × [age − 70])
with a score of 24–30 being inclusive (Mungas et al., 1996), objective
memory loss ascertained by performance on education adjusted scores
on the Wechsler Memory Scale Logical Memory II, Clinical Dementia
Rating Scale (CDR) of ≤0.5, modiﬁed Hachinski score b4, and Geriatrics
Depression Scale (GDS) b6. We also excluded persons with probable
dementia according toNational Institute of Neurological and Communi-
cative Disorders and Stroke/Alzheimer's Disease and Related Disorders
Association (MINCDS/ADRDA) criteria, and those having memory loss
frommedical, neurological, or psychiatric conditions,medication effects
or delirium.
2.2. Level II screening
From the remaining eligible volunteers, we acquired vital signs and
anthropometric measurements, and then performed detailed general
physical and neurological examinations. We collected fasting blood
samples to assess plasma lipoprotein/lipids, hemoglobin and hemato-
crit, basicmetabolic panel (BMP), rapid plasma reagin (RPR) andplasmalevels of thyroxine (T4), and thyroid stimulating hormone from all eligi-
ble volunteers.
The remaining qualiﬁed andwilling volunteers underwent amaximal
treadmill exercise test using the Bruce protocol (Bruce and Hornsten,
1969) to screen for cardiovascular disease (CVD). The testwas terminated
when the subject could no longer continue, or CVD signs and symptoms
occurred (American College of Sports Medicine Position Stand, 1998a).
CVD indicators including blood pressure, heart rate, and ECGwere record-
ed before the test, at the end of every exercise stage, and every 2 min for
6 min after discontinuing the test. The test was terminated if the subject
had N2-mV ST-segment depression, extra systole, chest pain, arrhyth-
mias, hypotension or dizziness, or signiﬁcant ST segment elevation during
the treadmill tests (American College of Sports Medicine Position Stand,
1998a; White and Evans, 2001). The maximal oxygen consumption
(VO2max) was determined using a validated customized on-line system
(K4b2 by Cosmed, Chicago Illinois). As part of the initial evaluation and
prior to the treadmill screening tests, each participant had a brain MRI
to exclude signiﬁcant intracranial pathology (such as clinically signiﬁcant
cerebrovascular disease including cortical infarcts, strategically located
subcortical gray matter or extensive white matter abnormalities). Prior
to randomization, study partners and subjects were instructed to
maintain regular caloric intake during the study period, and maintain
an American Heart Association Step 1 diet: b30% of energy from fat,
~55% from carbohydrate, ~15% from protein, and cholesterol intake
b300 mg/day.
2.3. Randomization and blinding procedures
Randomization of subjects occurred prior to baseline tests. All staff,
except those directly monitoring exercise-training, were blinded to
group assignments. The data were de-identiﬁed using assigned unique
identiﬁers for labeling and tracking.
2.4. Baseline testing
At the completion of dietary stabilization and randomization, sub-
jects were familiarized with treadmill screening tests, before undergo-
ing the actual treadmill exercise test. We then determined baseline
VO2max and endurance capacity, using a modiﬁed Bruce protocol. Dis-
continuation criteria for this test were similar to those used for the
level II screening test.
During the 24-hour period prior to blood drawing for baseline tests,
participants were instructed not to have anything by mouth, consume
no alcohol or smoke cigarettes, and to not use any anti-inﬂammatory
medications. Additionally, subjects were told to refrain from exercise
for 72 h prior to testing, and to conﬁrm that they had no infection in
the week prior to testing. For the gene expression analyses, and prior
to the initiation of exercise-training, we collected overnight fasting
blood samples using sterile techniques by personnel trained in phlebot-
omy, and stored samples in heparinized collection tubes. Subsequently,
the samples were centrifuged at 500 g after which the buffy coat layer
containing leukocyte population was removed and stored in aliquots
at−80 °C.
2.5. Aerobic exercise-training protocol
We inferred each subject's maximum heart rate from baseline
VO2max tests. Both the intervention (aerobic exercise) and control
(stretch exercise) groups underwent supervised training 3 times/
week.
The aerobic exercise protocol complied with the American
College of Sports Medicine Guidelines (ACSM) (American College of
Sports Medicine position stand, 1990), and included treadmill
walking or jogging, stair-stepping, and elliptical climbing. Subjects
underwent a warm up period, followed by exercise-training and
an appropriate cool-down period. Initial training sessions lasted
161O. Iyalomhe et al. / Experimental Gerontology 69 (2015) 159–16920 min at 50% VO2max, while study staff used records of exercise
heart rate and duration to monitor protocol compliance. During
each session, training duration increased by 5 min/week until sub-
jects completed 40 min of exercise at 50% VO2max. Subsequently,
training intensity was increased by 5% VO2max weekly until achiev-
ing 70% VO2max while taking necessary safety precautions. Partici-
pants were asked to add an unsupervised 45–60 min lower
intensity walk on the weekend after the ﬁrst 4–6 weeks of exercise.
Overall exercise-training lasted 6 months, and subjects continued
all interventions until the completion of ﬁnal testing.
2.6. Stretch exercise protocol
Static rather than dynamic stretch of joints increases ﬂexibility and
joint range, and prevents motion loss, but has minimal impact on
VO2max (American College of Sports Medicine Position Stand, 1998b).
As such, training of the stretch group consisted of maintaining exercise
positions for 15–30 s to produce a slight pull on the muscle but not to
the point of triggering the sensation of pain. Using different positions
for a total of about 40min, each stretch was directed at often tight mus-
cles (e.g., hamstrings, hip ﬂexors, calves and chest), and repeated slow-
ly, 3–5 times on each body side 3 days/week (American College of
Sports Medicine Position Stand, 1998b). To more closely match the in-
creasing intensity and duration of aerobic-exercise, stretch training
targeted hamstrings in week-1; hamstring + hip ﬂexors in week-2;
hamstring + hip ﬂexors + calves in week-3; and hamstring + hip
ﬂexors + calves + chest muscle in week-4, and continued until study
completion and ﬁnal testing.
2.7. Follow-up test at 6 months
After subjects completed the 6-month aerobic or stretch exercise-
training, all baseline tests (e.g., VO2max, blood tests formicroarray anal-
yses) were repeated using methods analogous to baseline testing.
2.8. Microarray analyses
The microarray analysis included data from 10 MCI subjects ran-
domly assigned to either an aerobic exercise (n = 5) or a stretch exer-
cise control (n = 5) group. To determine changes in global gene
expression proﬁles, we performed microarray analysis on blood sam-
ples collected before (baseline) and after a 6-month exercise-training
in the 10 MCI volunteers who completed the protocol. Total RNA was
isolated from buffy coat samples and extracted using the RNeasy Mini
Kit (QIAGEN, Valencia, CA) according to themanufacturer's instructions.
After the extraction, RNA concentration and purity (OD260/280) were
measured using the NanoDrop ND-1000 spectrophotometer (Thermo
Fischer Scientiﬁc, Waltham, MA, USA), and the RNA integrity number
(RIN) was determined using an Agilent 2100 Bioanalyzer Instrument
(Agilent, Santa Clara, CA, USA). We proﬁled gene expression using the
Illumina HumanHT-12 v4 Expression BeadChip platform containing
47,000 probes covering RefSeq and Unigene annotated genes (Illumina
Inc., San Diego, CA, USA). 500 ng total RNA was labeled using the
Illumina TotalPrep-96 RNA Ampliﬁcation Kit (Ambion, Inc., Austin,
TX). Brieﬂy, the protocol features ﬁrst- and second-strand reverse
transcription steps, followed by a single in vitro transcription (IVT) am-
pliﬁcation that incorporates biotin-labeled nucleotides to generate bio-
tinylated cRNA. The puriﬁed cRNAwas quantiﬁed and the fragment size
was determined using an Agilent 2100 Bioanalyzer Instrument (Agilent,
Santa Clara, CA, USA). Then, 750 ng of labeled biotinylated cRNA probe
was hybridized overnight to the Illumina HumanHT-12 v4 Expression
BeadChip. The hybridization, washing, and scanning were performed
according to the manufacturer's instructions. The BeadChips were
scanned using a HiScanSQ System (Illumina Inc., San Diego, CA, USA).
The microarray images were registered and extracted automatically
during the scan using the manufacturer's default settings.Ingenuity pathway analysis (IPA) was used to analyze conduits of
relevant genes. Genes with signiﬁcant changes in expression compared
to baseline values were determined by applying a paired t-test on each
individual gene, and using the cutoff combination of the Benjamini–
Hochberg multi-test with an adjusted p-value b 0.01 and absolute fold
change ≥ 2.0. Qualiﬁed genes were provided to the IPA program for
core analysis. Based on the context of molecular mechanisms stored in
the Ingenuity Database, networks were generated for up-regulated
and down-regulated genes that met the threshold. Using the Ingenuity
system for core analysis, corresponding networks were determined
from all genes with signiﬁcantly altered expression.
3. Results
We used microarrays to obtain gene expression proﬁles of human
blood cells that were derived from MCI subjects at baseline and after a
6-month intervention of aerobic or stretch exercise. The samples
consisted of AAs (3 males and 7 females) with ages as follows:
aerobic = 73 ± 5 years and stretch = 70 ± 9 years (mean ± standard
deviation). In total, 81 genes in our samplewere differentially expressed
in response to aerobic exercise-training (Fig. 1: aerobic exercise heat
map) compared to only 6 unique and non-overlapping genes in
the stretch-training group, using a cut-off p-value b 0.01 and fold
change ≥ 2.0. In analyses restricted to the 81 differentially expressed
genes obtained from the aerobic exercise group, the stretch group
showed no statistically signiﬁcant alteration in training-induced gene
expression proﬁles (fold change ≤ 2 at p ≥ 0.01) (Fig. 4: stretch exercise
heatmap). Many of the 81 geneswith altered expression in the exercise
group (Table 1) play important roles in immune function, cell survival
and inﬂammation.
Using the Ingenuity Knowledge Base, we determined biologically
relevant networks of genes using all the aerobic-exercise regulated
genes in this study (Figs. 2 and 3). Networks identiﬁed by the Inge-
nuity Knowledge Base library are premised on known interactions
amongst various genes. Speciﬁcally, we identiﬁed pathways consti-
tuting ribonuclease, RNase A family-2 (RNASE2), and interleukin-1
(IL-1), with RNASE2 signiﬁcantly down-regulated in this study
(Table 1). Similarly, the S100 calcium-binding protein family
(S100A8, S100A9, and S100A12), defensin (alpha-3, neutrophil-
speciﬁc) (DEFA1) and lysozyme (LYZ) (Figs. 1 and 2 and Table 1)
were also down-regulated. Contrary to the overall increased expres-
sion of anti-inﬂammatory genes in the aerobic exercise group, the
expression of S100A12 and LYZ increased 1.5 and 2.2 fold, respec-
tively, in the stretch-exercise control group, but at p N 0.01
(Table 2). The down-regulated genes in the aerobic exercise group
(Table 1) have important immunological and pro-inﬂammatory
properties. Three of the up-regulated genes (Table 1) in the expres-
sion data (parathymosin [PTMS]; Fig. 3), cytidine monophosphate
Neu5Ac synthetase [CMAS] and mitogen-activated protein kinase
kinase-2 [MAP2K2] (Fig. 2) have also been reported to exert signiﬁ-
cant immunological and anti-inﬂammatory properties, easing
the immune response when up-regulated (see the Discussion sec-
tion). Cadherin-1 (type-1, E-cadherin, epithelial) (CDH1), GRB2-
associated binding protein-1 (GAB1), and Ras homolog enriched in
brain (Rheb) are other up-regulated genes that play important
roles in neuronal survival and axon growth. Training-induced
up-regulation of these latter genes may promote neuronal survival
in AD.
At baseline, the aerobic exercise group had lower relative VO2max
(21.39 ml/kg/min) compared to the stretch group (26.48 ml/kg/min),
respectively. However, after the 6-month training intervention, the aer-
obic grouphad signiﬁcantly greater training-induced changes in relative
VO2max (+9.72ml/kg/min) compared to a reduction in the stretch ex-
ercise (−4.92 ml/kg/min) (see Fig. 5). The training-induced changes in
VO2max of the aerobic exercise group correlates with favorable changes
in gene expression after the intervention.
Fig. 1. Heat map of the 81 genes whose expressions were altered by a 6-month aerobic exercise training.
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Fig. 2.A network constituting some genes with altered expression after a 6-month aerobic exercise program (inﬂammation and cancer). Genes are represented by nodes. Nodes colored in
“red” represent up-regulated genes andnodes colored in “green” indicate down-regulated genes (p-value b 0.01, fold change ≥ 2), and the intensity of the color demonstrates the degree of
up/down-regulation when compared to normal levels. Uncolored nodes are genes not identiﬁed in this study but have been integrated into the Ingenuity Pathways system/memory.
Nodes are displayed using various shapes that represent the functional class of the gene product. Straight lines with arrows indicate the biological relationship between two nodes,
and the nature of the relationship between two different nodes is displayed by the edges. Edges are supported by scientiﬁc publications that are stored within the Ingenuity Pathways
Knowledge Base. This network was updated using the 2014 Ingenuity Pathways software.
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We observed that a 6-month standardized aerobic exercise-training
regimen signiﬁcantly altered the regulation of several genes. Particular-
ly, robust training-induced effectswere noted on the regulation of genes
involved in inﬂammation, cell survival and axonal growth. Our anal-
ysis revealed the down-regulation of three pro-inﬂammatory genes
(S100A8, S100A9 and S100A12) in the S100 family. By promoting in-
ﬂammation at their steady state, these genes likely play an important
role in AD pathology (Sen and Belli, 2007; Shepherd et al., 2006; Ha et al.,
2010). On the other hand, 3 genes exerting anti-inﬂammatory properties
and others involved in neuronal survival and axonal growth were up-
regulated (see below). Because of the centrality of inﬂammation toADpa-
thology, these results may, in part, mechanistically explain the beneﬁcial
effects of exercise on cognition. If conﬁrmed in future studies, directed
modulation of the expression of pro- and anti-inﬂammatory genes, and
the enhancement of genes promoting neuronal survival, may offer useful
interventions, and potentially become targets for the development of
drugs to delay AD development in those at risk.4.1. Down-regulation of pro-inﬂammatory genes
It is widely accepted that neuroinﬂammation accompanied by
excessive expression of immune cytokines is a “principal culprit” of
sporadic AD (Streit et al., 2004). Pro-inﬂammatory proteins such as
S100a8/a9 have been demonstrated to be markedly increased in re-
sponse to cytokine stimuli (Hsu et al., 2009; Liang et al., 2006). In ad-
dition, S100a8/a9 may act as leukocyte chemo-attractants
(Lackmann et al., 1993) and induce the expression of pro-
inﬂammatory cytokines (Benedyk et al., 2007), causing a positive
feedback in inﬂammation. In aged mice and humans, increases in
the mRNA levels of S100a8 and S100a9 have been demonstrated in
multiple tissues including the central nervous system (Swindell et al.,
2013). Recently, S100a9 (calgranulin B), an important pro-inﬂammatory
mediator in acute and chronic inﬂammation (Foell et al., 2004;
Gebhardt et al., 2006, 2002), was identiﬁed as a contributor to amyloid
plaque accumulation (Zhang et al., 2012). In support of its role in AD,
knockdown of S100a9 expression reduced amyloid plaque abundance
and improved cognition in a mouse model (Ha et al., 2010). It appears
Fig. 3. A network constituting some genes with altered expression after a 6-month aerobic exercise program (cancer, cell cycle, and cellular signaling). Genes are represented by nodes.
Nodes colored in “red” represent up-regulated genes and nodes colored in “green” indicate down-regulated genes (p-value b 0.01, fold change ≥ 2), and the intensity of the color demon-
strates the degree of up/down-regulation when compared to normal levels. Uncolored nodes are genes not identiﬁed in this study but have been integrated into the Ingenuity Pathways
system/memory. Nodes are displayed using various shapes that represent the functional class of the gene product. Straight lines with arrows indicate the biological relationship between
two nodes, and the nature of the relationship between two different nodes is displayed by the edges. Edges are supported by scientiﬁc publications that are stored within the Ingenuity
Pathways Knowledge Base. This network was updated using the 2014 Ingenuity Pathways software.
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ulation of amyloid precursor protein and/or Aβ production (Maarouf
et al., 2011), inducing the production of pro-inﬂammatory proteins such
as S100a9 (Ha et al., 2010). These pro-inﬂammatory proteins may drive
AD neuropathology by promoting amyloid plaque formation. Therefore,
aerobic exercise training-induced down-regulation of the S100 family of
genes may ameliorate the destructive effects of inﬂammatory molecules
and preserve cognition.
S100A12 is another pro-inﬂammatory protein that shares sequence
homology with S100A8 and S100A9 (Yang et al., 2001). It is a potent
chemo-attractant for monocytoid cells (Miranda et al., 2001) and in-
duces the expression of adhesion molecules and pro-inﬂammatory
cytokines (Hofmann et al., 1999). It activates various cell types by bind-
ing the receptor for advanced glycosylation end products (RAGE) asso-
ciated with AD-characteristic lesions (Sasaki et al., 2001). Secretion of
S100A9 during inﬂammation promotes the formation of amyloid
plaques (Zhang et al., 2012) and the co-existence of both S100A9 and
S100A12 in pathological lesions of AD support their roles in AD patho-
genesis (Shepherd et al., 2006).
Given the enhancing effects of exercise on memory (Barnes et al.,
2008; Yaffe et al., 2001; Podewils et al., 2005; Laurin et al., 2001;Middleton et al., 2008), signiﬁcant exercise-training-induced down-
regulation of pro-inﬂammatory genes in olderMCI subjects, maymech-
anistically relate ﬁtness effects to reduced neuro-inﬂammation and AD
pathogenesis. Indeed, growing independent evidence now suggests
that moderate exercise can modulate inﬂammation, decrease pro-
inﬂammatory cytokines (You et al., 2013; Nascimento et al., 2014),
and therefore, preserve neuronal integrity, and potentially, preserve
cognition (Porto et al., 2015; Erickson et al., 2011).
4.2. Up-regulation of anti-inﬂammatory genes
Our results also show that aerobic-exercise training up-regulated
three genes (PTMS, CMAS,MAP2K2) involved in reduced immunological
response.
PTMS likely mediates immune function by blocking the effects of
prothymosin alpha (Abiko and Sekino, 1991), and reduces the produc-
tion of IL-2 and IL-2R (IL-2 receptor) required for proliferation of
CD4+ T cells (Baxevanis et al., 1988, 1990). As a pro-inﬂammatory cyto-
kine, IL-2 stimulates lymphocytes, monocytes, lymphokine-activated kill-
er cells, and natural killer cells critical to immune function (Liao et al.,
2011). Consistent with the idea that anti-inﬂammatory genes may be
Fig. 4. Heat map of the 81 genes in the stretch control group, whose expression were altered by a 6-month aerobic exercise training.
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Table 1
Notable genes involved in immune function, promotion of neuronal survival and axonal growth with ≥2 fold change (p b 0.01) after a 6-month aerobic exercise-training program.
Symbol Name p-value Fold-change Function
Genes involved in immunological function
DEFA3 Defensin, alpha-3, neutrophil-speciﬁc 0.009578 −3.3 Kill microbes by permeabilizing their plasma membrane (Nature Reviews
Immunology (2003) 3, 710–720)
C15orf51 Dynamin-1 pseudogene 0.00554 −3.3 Unknown
RNASE2 Ribonuclease, RNase A family-2 0.001291 −3.1 Selectively chemotactic for dendritic cells (Blood (2003) 102, 3396–3403)
S100A8 S100 calcium binding protein A8 0.000489 −2.8 Potent ampliﬁer of inﬂammation in autoimmunity and in cancer
development/spread (Gebhardt et al., 2002, 2006; see the Discussion section)
LYZ Lysozyme 0.00392 −2.6 Innate immunity, monocyte-macrophage system and enhanced activity of immune
agents (Ric Clin Lab (1978) 8, 211–231)
S100A9 S100 calcium binding protein A9 0.001877 −2.3 Potent ampliﬁer of inﬂammation in autoimmunity and in cancer
development/spread (Gebhardt et al., 2002, 2006; see the Discussion section)
SNORD115-25 Small nucleolar RNA, C/D box 115-25 0.007939 −2.1 RNA methylation (Nature (1998) 383, 732–735)
S100A12 S100 calcium binding protein A12 0.002473 −2.0 Regulation of inﬂammatory processes and immune response (Shepherd et al.,
2006; see the Discussion section)
MAP2K2 Mitogen-activated protein kinase kinase-2 0.007647 2.2 Role in mitogen growth factor signal transduction (Pages et al., 1993; Roovers and
Assoian, 2000; Yi et al., 2002; see the Discussion section)
PTMS Parathymosin 0.004324 2.5 Mediate immune function by blocking the effect of prothymosin alpha (Baxevanis
et al., 1988, 1990; Walker et al., 2001; see the Discussion section)
CMAS Cytidine monophosphate Neu5Ac synthetase 0.005699 2.9 Sialylation of glycoproteins (Proc Natl Acad Sci USA (1998) 95, 9140–9145; see the
Discussion section)
Genes promoting neuronal survival and axon growth
GAB1 GRB2-associated binding protein-1 0.007016 3.1 Involved in cell growth and enhancement of neuronal survival through EGFR (Yart
et al., 2003; Hoeben et al., 2013; see the Discussion section)
CDH1 Cadherin-1, type-1, E-cadherin (epithelial) 0.007616 2.2 Regulates cell–cell adhesions, mobility, axonal growth, synaptic control (Almeida
et al., 2005; Maestre et al., 2008; see the Discussion section)
RHEB Ras homolog enriched in brain 0.006289 2.1 Promotes neuronal survival and axon regeneration through mTOR pathway
(Cheng et al., 2011, Yang et al., 2006; see the Discussion section)
166 O. Iyalomhe et al. / Experimental Gerontology 69 (2015) 159–169down-regulated in AD, down-regulation of parathymosin was noted in
amyloid beta-stimulated microglia from post-mortem cases (Walker
et al., 2001). Given the pivotal role of inﬂammation in AD, exercise-
induced up-regulation of parathymosin and consequent modulation of
the immune response may reduce inﬂammation and beneﬁt cognitive
processes.
CMAS, the second up-regulated anti-inﬂammatory gene in
our expression data, encodes the enzyme N-acetylneuraminate
cytidylyltransferase responsible for adding sialic acid residues to
glycoproteins and glycolipids in humans (Varki and Gagneux,
2012). Neuronal membranes possess sialic acid which promotes
neural transmission, maintains ganglioside structure in synapto-
genesis (Wang and Brand-Miller, 2003), and enhances brain devel-
opment and learning (Wang, 2012). Removal of sialic acid residues
from the neuronal glycocalyx activates the classical complement
pathway and phagocytosis by microglia (Linnartz et al., 2012).
Therefore, training-induced up-regulation of CMAS expression,
may enhance sialic acid-dependent glycosylation of neuronal
membranes, protect neurons against complement-induced loss,
and potentially reduce brain inﬂammation, neuronal degeneration
and cognitive loss.
MAP2K2, the third up-regulated anti-inﬂammatory gene in our
data, encodes a dual speciﬁcity protein kinase belonging to the
MAP kinase family. This protein is essential for mitogen growth fac-
tor signal transduction and cell cycle progression (Pages et al., 1993;
Roovers and Assoian, 2000). Although activated MAP2K2 may pro-
mote the production of some pro-inﬂammatory cytokines
(Thalhamer et al., 2008), its enhancement of IL-10 production may
inhibit the syntheses of IFN-gamma and TNF-alpha (Yi et al., 2002;
Spagnoli et al., 1993). Therefore, as a differential immunemodulator,
increased expression of MAP2K2 by a 6-month aerobic exercise-
training may ease amyloid-induced immunologic responses, and
perhaps preserve cognition. Though we observed no signiﬁcant
training-induced fold change in the expression of the amyloid pre-
cursor protein (APP) gene in our samples, the direct interaction of
both CMAS and PTMS with APP (Fig. 3) may indicate their potential
roles in AD pathogenesis.4.3. Genes promoting neuronal survival
In our data, a 6-month aerobic-exercise program also up-regulated
the expression of three genes (CDH1, GAB1, Rheb) that can promote
neuronal survival and axon growth.
CDH1 is implicated in fundamental nervous system processes, such as
axonal growth, patterning (Konishi et al., 2004; Lasorella et al., 2006), and
synaptic control (Juo and Kaplan, 2004; van Roessel et al., 2004). In addi-
tion, the degradative action of the CDH1-anaphase-promoting complex
(APC) is an essential survival mechanism in post-mitotic neurons
(Almeida et al., 2005). Given that the inactivation of CDH1 contributes
to neuronal excitotoxic death from accumulation of cyclin B1 in
degenerating brain areas in Alzheimer's disease (Bossy-Wetzel et al.,
2004; Maestre et al., 2008), aerobic-exercise training-induced up-
regulation of CDH1 may be vital to neuronal survival and reduced
neurodegeneration.
GAB1 is a docking/scaffolding molecule which transduces signals
from a variety of tyrosine kinases, including epidermal growth factor re-
ceptor (EGFR)-induced signaling (Yart et al., 2003; Hoeben et al., 2013).
Given previously reported impairment of learning and memory in EGF-
like growth factor knock-out mice (Oyagi et al., 2011), it is possible that
EGFR acts as a mitogen for neural stem and progenitor cells (NS/NPCs)
in the central nervous system (CNS), integrating EGF/TGF-α signaling
in away that affects neuronal differentiation (Anchan et al., 1991), surviv-
al (Morrison et al., 1987, 1988; Alexi and Hefti, 1993), and glial prolifera-
tion (Leutz and Schachner, 1981; Simpson et al., 1982). It is possible that
ﬁtness-induced up-regulation of these genesmay enhance neuronal plas-
ticity and stem the tide of neurodegeneration.
Rheb is a small GTPase that activatesmTOR (Cheng et al., 2011; Yang
et al., 2006; Sato et al., 2009). The mammalian target of rapamycin
(mTOR) is a serine/threonine protein kinase which regulates cellular
growth, and helps to integrate growth factor activitywith other external
signals (Wullschleger et al., 2006). Because Rheb–mTOR signaling
confers axon protection (Cheng et al., 2011), its activationmay promote
neuronal survival and axon regeneration (Park et al., 2008). Given
that axonal loss is central to AD and other neurodegenerative disor-
ders, the role of Rheb–mTOR in neurodegenerative pathogenesis
Table 2
Notable genes with ≥1.5 fold change in the 6-month stretch control group.⁎
Symbol Name p-value Fold change Function
TIMM23 Translocase of inner mitochondrial membrane 23 homolog
(yeast)
0.2468806 1.5 Mediates the transport of transit peptide-containing proteins
across the membrane
APOBEC3C Apolipoprotein B mRNA editing enzyme, catalytic
polypeptide-like 3C
0.2501128 1.5 Have roles in growth or cell cycle control
S100A12 S100 calcium binding protein A12 0.0490725 1.5 Regulation of inﬂammatory processes and immune response
C1D C1D nuclear receptor corepressor 0.0963231 1.5 Localized in the nucleus and encodes DNA binding and
apoptosis-inducing protein
CHMP5 Charged multivesicular body protein 5 0.0581199 1.6 Its complex is involved in degradation of surface receptor proteins
and formation of endocytic multivesicular bodies (MVBs)
PCMTD2 Protein-L-isoaspartate (D-aspartate)
O-methyltransferase domain containing 2
0.039969 1.9 Protein coding gene
LYZ Lysozyme 0.0460297 2.2 Enhances the activity of immune agents (Ric Clin Lab (1978) 8,
211–231)
SNORD115-25 Small nucleolar RNA, C/D box 115-25 0.1892712 −1.6 RNA methylation (Nature (1998) 383, 732–735)
⁎ Note that the p-values are N0.01.
167O. Iyalomhe et al. / Experimental Gerontology 69 (2015) 159–169must be considered. In select brain regions, it is believed that axons
and their synaptic terminals but not neuronal cell bodies, are the
initial loci of some neurodegeneration, a cause of early disease man-
ifestations and clinical progression (Cheng et al., 2010; Selkoe,
2002). Therefore, exercise-induced up-regulation of expression of
Rheb might promote Rheb–mTOR signaling, enhance the survival of
neurons and regeneration of axons, and potentially improve cogni-
tive impairment.
An important ﬁnding from this study is the concomitant training-
induced increase in relative VO2max in the aerobic but not the stretch
exercise group. Though the exact molecular mechanisms which under-
lie the changes in expression are not completely understood, the con-
comitant training-induced changes in VO2max suggest that training
adaptation and cardiovascular ﬁtness, can promote advantageous
effects at the molecular level.
4.4. Limitations and summary
One limitation of this study is that gene expression data were de-
rived from blood cells (and not the brain or cerebrospinal ﬂuid), and
are yet to be correlated with the AD clinical phenotype. However, it is
likely that such work will yield positive results, given that exercise has
been demonstrated to promote neurogenesis in the dentate gyrus of
exercising mice and in humans (Pereira et al., 2007). Similarly, the in-
tensity rating of physical activity and reduced TNF-alpha, were associat-
ed with increased brain volume on magnetic resonance imaging
(Braskie et al., 2014). Theseﬁndings are consistentwith our observation
of increased expression of neuronal and axonal survival genes in aerobic
but not in stretch exercise training. Recently, Swindell and colleagues
showed signiﬁcantly increased expression of S100 genes in both bloodFig. 5. Baseline and 6-month VO2max (ml/kg/min) measurements in aerobic and stretch
exercise groups.and the hippocampus of aging human tissues (Swindell et al., 2013),
suggesting that molecular aspects of the underlying pathology may
have a systemic component, making blood cell-derived data relevant.
These observations are consistent with existing evidence arguing that
exercise adaptation can decrease the levels of pro-inﬂammatory cyto-
kines (You et al., 2013; Nascimento et al., 2014).
A second limitation of this study is the relatively small sample size. A
recent microarray study by Stretch et al. examining sex-based differ-
ences in gene expression concluded that a larger sample size would
be helpful (Stretch et al., 2013). However, compared to the cross-
sectional nature of the Stretch et al. study, the randomized, controlled,
and supervised clinical trial approach of this rigorous exercise study in
AA MCIs, limit the impact of the small sample size. To analyze the
training-induced changes in gene expression, aggregate fold changes
for the same set of individuals in each groupwere independently calcu-
lated, analyzed and normalizedwithin one “average” background of the
stretch or aerobic exercise group. The physiological signiﬁcance of the
identiﬁed changes is plausible since the differentially expressed genes
could be grouped into functional pathways, with notable conformity
in the direction of their regulation (increase or decrease) in each path-
way. Moreover, the extent of overlap of such changes likely indicates
whether they are due to chance or the intervention. Had signiﬁcant
overlap in observed differential expression occurred between the 2
groups (aerobic versus stretch), the overall results may have inspired
less conﬁdence. Nonetheless, because a larger sample size would be
helpful, caution is warranted in interpreting the results.
In summary, our data show that aerobic-exercise can down-regulate
the expression of pro-inﬂammatory genes, concomitantly up-regulate
anti-inﬂammatory genes, and collectively reduce inﬂammation. Simul-
taneously, aerobic exercise promotes the expression of genes involved
in axonal growth and neuronal survival. Given the harmful attributes
of inﬂammation on neuronal survival and ADpathology, it appears like-
ly that the enhancing effects of aerobic-exercise on cognition may be
mediated through reduction in inﬂammation. Overall, our results
support the role of gene–environment interactions on health. Future
RT-polymerase chain reaction studies should consider the use of cere-
brospinal ﬂuid to validate our semi-quantitative observations.Acknowledgments
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